Chai Discovery's $400M Series C triples its value to $3.8bn, a fresh sign that AI drug discovery has moved from promise to deployment at big pharma.

Chai Discovery Announces Collaboration with Novartis to Advance AI-Driven Antibody Discovery

Chai Discovery is raising $400M at a $3.4B valuation for AI drug discovery, backed by Pfizer, Eli Lilly, and OpenAI, raising questions for crypto's DeSci